92 related articles for article (PubMed ID: 2241954)
21. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
22. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
Radomski MW; Palmer RM; Moncada S
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5193-7. PubMed ID: 1695013
[TBL] [Abstract][Full Text] [Related]
23. Rat mast cells inhibit platelet aggregation by releasing a nitric oxide-like factor: influence of histamine release.
Mannaioni PF; Masini E; Pistelli A; Salvemini D; Vane JR
Agents Actions Suppl; 1991; 33():423-8. PubMed ID: 1711277
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells.
Junquero DC; Scott-Burden T; Schini VB; Vanhoutte PM
J Physiol; 1992 Aug; 454():451-65. PubMed ID: 1282159
[TBL] [Abstract][Full Text] [Related]
25. Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release.
Hogaboam CM; Befus AD; Wallace JL
J Immunol; 1993 Oct; 151(7):3767-74. PubMed ID: 8397260
[TBL] [Abstract][Full Text] [Related]
26. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets.
Bani D; Bigazzi M; Masini E; Bani G; Sacchi TB
Lab Invest; 1995 Nov; 73(5):709-16. PubMed ID: 7474945
[TBL] [Abstract][Full Text] [Related]
27. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.
Crane MS; Rossi AG; Megson IL
Br J Pharmacol; 2005 Mar; 144(6):849-59. PubMed ID: 15685209
[TBL] [Abstract][Full Text] [Related]
28. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide derived from endothelial cells inhibits Na+/H+ exchange in rabbit platelets activated by thrombin.
Chen H; Guo ZG
Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):333-7. PubMed ID: 10452119
[TBL] [Abstract][Full Text] [Related]
30. The calcium modulator nifedipine exerts its antiaggregatory property via a nitric oxide mediated process.
Berkels R; Klaus W; Boller M; Rösen R
Thromb Haemost; 1994 Aug; 72(2):309-12. PubMed ID: 7831670
[TBL] [Abstract][Full Text] [Related]
31. L-NMMA in brain microcirculation of mice is inhibited by blockade of cyclooxygenase and by superoxide dismutase.
Rosenblum WI; Nishimura H; Nelson GH
Am J Physiol; 1992 May; 262(5 Pt 2):H1343-9. PubMed ID: 1590436
[TBL] [Abstract][Full Text] [Related]
32. Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
Hirafuji M; Shinoda H
Br J Pharmacol; 1993 Jun; 109(2):524-9. PubMed ID: 8358552
[TBL] [Abstract][Full Text] [Related]
33. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
[TBL] [Abstract][Full Text] [Related]
34. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
McCall TB; Feelisch M; Palmer RM; Moncada S
Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
[TBL] [Abstract][Full Text] [Related]
35. Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line.
Zembowicz A; Vane JR
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2051-5. PubMed ID: 1372433
[TBL] [Abstract][Full Text] [Related]
36. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
Salvemini D; Pistelli A; Anggard E
Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
[TBL] [Abstract][Full Text] [Related]
37. Cloned murine T lymphocytes synthesize a molecule with the biological characteristics of nitric oxide.
Kirk SJ; Regan MC; Barbul A
Biochem Biophys Res Commun; 1990 Dec; 173(2):660-5. PubMed ID: 2175602
[TBL] [Abstract][Full Text] [Related]
38. [Nitric oxide-dependent inhibition of platelet aggregation in elderly patients with hypercholesterolemia].
Ueda S; Katagiri M; Matsumoto Y; Nishimura T; Matsushita S; Mori M; Ozawa T; Orimo H
Nihon Ronen Igakkai Zasshi; 2001 Mar; 38(2):177-84. PubMed ID: 11305031
[TBL] [Abstract][Full Text] [Related]
39. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation.
Laffi G; Foschi M; Masini E; Simoni A; Mugnai L; La Villa G; Barletta G; Mannaioni PF; Gentilini P
Hepatology; 1995 Dec; 22(6):1666-73. PubMed ID: 7489972
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide.
Salvemini D; Mollace V; Pistelli A; Anggard E; Vane J
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):982-6. PubMed ID: 1310543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
